Skip to main content
. 2021 Nov 29;5:98. doi: 10.1038/s41698-021-00237-5

Fig. 3. Landscape of co-alterations with KRAS G12C in Non-small Cell Lung Cancer.

Fig. 3

Co-occurring genomic alterations found in KRAS G12C mutant NSCLC patients (n = 560, cBioPortal.org) including those that have combinatorial strategies planned in clinical trials25,26.